1. Untreated heart failure: clinical and neurotiating vasodilatatory prostaglandins and endocrine effects of introducing diuretics;Bayliss, J.; Norell, M.; Canepa-Anson, R.; Sutton, G.; Poole-Wilson, P.;Br Heart J inhibiting the degradation of bradykinin. It is,1987
2. Vasovagal reactions to as yet unclear what these general interactions cardiovascular drugs: the first dose effect;Semple, P.F.; Thoren, P.; Lever, A.F.,1988
3. inhibitors.30 We are unaware of any experimental or clinical studies indicating the relevance of Struthers AD. A survey of current use of angiotensin converting enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure;McMurray, J.; Lang, C.C.; Maclean, D.D.; McDevitt, D.G.;Scott Med J; these interactions to the response to ACE inhibitors in heart failure,1989
4. A liquid chromatography assisted assay for angiotensin converting enzyme (peptidyl dipeptidase) in differential blood pressure responses observed are unlikely to be explained through differences serum;Chiknas, S.G.;Clin Chem,1979
5. Angiotensin converting enzyme codynamics inhibitors: relationship between pharmaand pharmacokinetics. Clin Pharmacokinet falls can be associated with benefit.3';Belz, G.G.; Kirch, W.; Kleinbloesem, C.H.